Literature DB >> 21624624

Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.

S J A van den Bogaard1, E M Dumas, L Ferrarini, J Milles, M A van Buchem, J van der Grond, R A C Roos.   

Abstract

Huntington's disease (HD) is characterized by brain atrophy. Localized atrophy of a specific structure could potentially be a more sensitive biomarker reflecting neuropathologic changes rather than global volume variation. We examined 90 TRACK-HD participants of which 30 were premanifest HD, 30 were manifest HD and 30 were controls. Using FMRIB's Integrated Registration and Segmentation Tool, segmentations were obtained for the pallidum, caudate nucleus, putamen, thalamus, accumbens nucleus, amygdala, and hippocampus and overall volumes were calculated. A point distribution model of each structure was obtained using Growing and Adaptive Meshes. Permutation testing between groups was performed to detect local displacement in shape between groups. In premanifest HD overall volume loss occurred in the putamen, accumbens and caudate nucleus. Overall volume reductions in manifest HD were found in all subcortical structures, except the amygdala, as compared to controls. In premanifest HD shape analysis showed small areas of displacement in the putamen, pallidum, accumbens and caudate nucleus. When the premanifest group was split into two groups according to predicted disease onset, the premanifest HD group close to expected disease onset showed more pronounced displacements in caudate nucleus and putamen compared to premanifest HD far from disease onset or the total premanifest group. Analysis of shape in manifest HD showed widespread shape differences, most prominently in the caudal part of the accumbens nucleus, body of the caudate nucleus, putamen and dorsal part of the pallidum. We conclude that shape analysis provides new insights in localized intrastructural atrophy patterns in HD, but can also potentially serve as specific target areas for disease tracking.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21624624     DOI: 10.1016/j.jns.2011.05.015

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  24 in total

1.  Surface-based morphometry reveals caudate subnuclear structural damage in patients with premotor Huntington disease.

Authors:  Hosung Kim; Ji-Hoon Kim; Katherine L Possin; Joseph Winer; Michael D Geschwind; Duan Xu; Christopher P Hess
Journal:  Brain Imaging Behav       Date:  2017-10       Impact factor: 3.978

2.  Differential putaminal morphology in Huntington's disease, frontotemporal dementia and Alzheimer's disease.

Authors:  Jeffrey C L Looi; Priya Rajagopalan; Mark Walterfang; Sarah K Madsen; Paul M Thompson; Matthew D Macfarlane; Chris Ching; Phyllis Chua; Dennis Velakoulis
Journal:  Aust N Z J Psychiatry       Date:  2012-09-18       Impact factor: 5.744

3.  Regional atrophy associated with cognitive and motor function in prodromal Huntington disease.

Authors:  Elizabeth H Aylward; Deborah L Harrington; James A Mills; Peggy C Nopoulos; Christopher A Ross; Jeffrey D Long; Dawei Liu; Holly K Westervelt; Jane S Paulsen
Journal:  J Huntingtons Dis       Date:  2013

4.  Neurotrophin receptor p75(NTR) mediates Huntington's disease-associated synaptic and memory dysfunction.

Authors:  Verónica Brito; Albert Giralt; Lilian Enriquez-Barreto; Mar Puigdellívol; Nuria Suelves; Alfonsa Zamora-Moratalla; Jesús J Ballesteros; Eduardo D Martín; Nuria Dominguez-Iturza; Miguel Morales; Jordi Alberch; Sílvia Ginés
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

Review 5.  Huntington disease: natural history, biomarkers and prospects for therapeutics.

Authors:  Christopher A Ross; Elizabeth H Aylward; Edward J Wild; Douglas R Langbehn; Jeffrey D Long; John H Warner; Rachael I Scahill; Blair R Leavitt; Julie C Stout; Jane S Paulsen; Ralf Reilmann; Paul G Unschuld; Alice Wexler; Russell L Margolis; Sarah J Tabrizi
Journal:  Nat Rev Neurol       Date:  2014-03-11       Impact factor: 42.937

6.  Differential effects of SNARE-dependent gliotransmission on behavioral phenotypes in a mouse model of Huntington's disease.

Authors:  Annesha C King; Tara E Wood; Efrain Rodriguez; Vladimir Parpura; Michelle Gray
Journal:  Exp Neurol       Date:  2020-05-07       Impact factor: 5.330

7.  Effects of social adversity and HIV on subcortical shape and neurocognitive function.

Authors:  April D Thames; Taylor P Kuhn; Zanjbeel Mahmood; Robert M Bilder; Timothy J Williamson; Elyse J Singer; Alyssa Arentoft
Journal:  Brain Imaging Behav       Date:  2018-02       Impact factor: 3.978

8.  Longitudinal resting state fMRI analysis in healthy controls and premanifest Huntington's disease gene carriers: a three-year follow-up study.

Authors:  Omar F F Odish; Annette A van den Berg-Huysmans; Simon J A van den Bogaard; Eve M Dumas; Ellen P Hart; Serge A R B Rombouts; Jeroen van der Grond; Raymund A C Roos
Journal:  Hum Brain Mapp       Date:  2014-08-19       Impact factor: 5.038

9.  Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis.

Authors:  Laurent Younes; J Tilak Ratnanather; Timothy Brown; Elizabeth Aylward; Peg Nopoulos; Hans Johnson; Vincent A Magnotta; Jane S Paulsen; Russell L Margolis; Roger L Albin; Michael I Miller; Christopher A Ross
Journal:  Hum Brain Mapp       Date:  2012-12-20       Impact factor: 5.038

10.  Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice.

Authors:  Y P Deng; T Wong; C Bricker-Anthony; B Deng; A Reiner
Journal:  Neurobiol Dis       Date:  2013-08-19       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.